Antithrombotic Therapy and Outcomes of Patients With New-Onset Transient Atrial Fibrillation After ST-Segment Elevation Myocardial Infarction
Conclusions:
There is not a widely accepted treatment algorithm in patients with STEMI who complicated with new-onset AF in clinical guidelines. The current study indicated that transient form of new-onset AF might not require long-term VKA. Besides, addition of VKA to DAPT therapy may increase the rates of major and minor bleeding.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Original Investigations Source Type: research
More News: Angioplasty | Aspirin | Atrial Fibrillation | Bleeding | Clopidogrel | Coronary Angioplasty | Coumadin | Drugs & Pharmacology | Heart Attack | Ischemic Stroke | Percutaneous Coronary Intervention | Plavix | Statistics | Stroke | Study | Vitamin K | Vitamins | Warfarin